BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BRAVEHEART who wrote (39)	2/1/1999 1:05:00 PM
From: JMarcus	of 423

I'm trying to reach Paul Herron again so that I can get answers to all of your questions. Until the company's website gets up later this week, you can find all of the press releases at fkpi.com According to the June 18 press release, the six tumor types that are the target of the Phase 2 trial are ovarian, melanoma, pancreatic, non-small cell lung, renal cell carcinoma and colon cancer. More later. Nice price move today. JMarcus

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next